Global Biopharmaceutical CDMO Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Biopharmaceutical CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biopharmaceutical CDMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biopharmaceutical CDMO market in any manner.
Global Biopharmaceutical CDMO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Lonza
WuXi AppTec
Catalent
Thermo Fisher
Recipharm
Samsung Biologics
Siegfried
Delpharm
Boehringer Ingelheim
Aenova Group
AGC Parma Chemicals
GenScript
ProBioGen
KBI Biopharma
3P Biopharmaceuticals
Rentschler Biopharma
Northway Biotech
Market Segmentation (by Type)
Development and Manufacturing CDMOs
Clinical Trial Material CDMOs
Fill-Finish CDMOs
Other
Market Segmentation (by Application)
Pharmaceutical Company
Biotechnology Company
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biopharmaceutical CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Biopharmaceutical CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biopharmaceutical CDMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biopharmaceutical CDMO market in any manner.
Global Biopharmaceutical CDMO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Lonza
WuXi AppTec
Catalent
Thermo Fisher
Recipharm
Samsung Biologics
Siegfried
Delpharm
Boehringer Ingelheim
Aenova Group
AGC Parma Chemicals
GenScript
ProBioGen
KBI Biopharma
3P Biopharmaceuticals
Rentschler Biopharma
Northway Biotech
Market Segmentation (by Type)
Development and Manufacturing CDMOs
Clinical Trial Material CDMOs
Fill-Finish CDMOs
Other
Market Segmentation (by Application)
Pharmaceutical Company
Biotechnology Company
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Biopharmaceutical CDMO Market
- Overview of the regional outlook of the Biopharmaceutical CDMO Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biopharmaceutical CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Biopharmaceutical CDMO
1.2 Key Market Segments
1.2.1 Biopharmaceutical CDMO Segment by Type
1.2.2 Biopharmaceutical CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOPHARMACEUTICAL CDMO MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biopharmaceutical CDMO Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Biopharmaceutical CDMO Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOPHARMACEUTICAL CDMO MARKET COMPETITIVE LANDSCAPE
3.1 Global Biopharmaceutical CDMO Sales by Manufacturers (2019-2024)
3.2 Global Biopharmaceutical CDMO Revenue Market Share by Manufacturers (2019-2024)
3.3 Biopharmaceutical CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biopharmaceutical CDMO Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biopharmaceutical CDMO Sales Sites, Area Served, Product Type
3.6 Biopharmaceutical CDMO Market Competitive Situation and Trends
3.6.1 Biopharmaceutical CDMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biopharmaceutical CDMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIOPHARMACEUTICAL CDMO INDUSTRY CHAIN ANALYSIS
4.1 Biopharmaceutical CDMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOPHARMACEUTICAL CDMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BIOPHARMACEUTICAL CDMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biopharmaceutical CDMO Sales Market Share by Type (2019-2024)
6.3 Global Biopharmaceutical CDMO Market Size Market Share by Type (2019-2024)
6.4 Global Biopharmaceutical CDMO Price by Type (2019-2024)
7 BIOPHARMACEUTICAL CDMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biopharmaceutical CDMO Market Sales by Application (2019-2024)
7.3 Global Biopharmaceutical CDMO Market Size (M USD) by Application (2019-2024)
7.4 Global Biopharmaceutical CDMO Sales Growth Rate by Application (2019-2024)
8 BIOPHARMACEUTICAL CDMO MARKET SEGMENTATION BY REGION
8.1 Global Biopharmaceutical CDMO Sales by Region
8.1.1 Global Biopharmaceutical CDMO Sales by Region
8.1.2 Global Biopharmaceutical CDMO Sales Market Share by Region
8.2 North America
8.2.1 North America Biopharmaceutical CDMO Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biopharmaceutical CDMO Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biopharmaceutical CDMO Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biopharmaceutical CDMO Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biopharmaceutical CDMO Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Lonza
9.1.1 Lonza Biopharmaceutical CDMO Basic Information
9.1.2 Lonza Biopharmaceutical CDMO Product Overview
9.1.3 Lonza Biopharmaceutical CDMO Product Market Performance
9.1.4 Lonza Business Overview
9.1.5 Lonza Biopharmaceutical CDMO SWOT Analysis
9.1.6 Lonza Recent Developments
9.2 WuXi AppTec
9.2.1 WuXi AppTec Biopharmaceutical CDMO Basic Information
9.2.2 WuXi AppTec Biopharmaceutical CDMO Product Overview
9.2.3 WuXi AppTec Biopharmaceutical CDMO Product Market Performance
9.2.4 WuXi AppTec Business Overview
9.2.5 WuXi AppTec Biopharmaceutical CDMO SWOT Analysis
9.2.6 WuXi AppTec Recent Developments
9.3 Catalent
9.3.1 Catalent Biopharmaceutical CDMO Basic Information
9.3.2 Catalent Biopharmaceutical CDMO Product Overview
9.3.3 Catalent Biopharmaceutical CDMO Product Market Performance
9.3.4 Catalent Biopharmaceutical CDMO SWOT Analysis
9.3.5 Catalent Business Overview
9.3.6 Catalent Recent Developments
9.4 Thermo Fisher
9.4.1 Thermo Fisher Biopharmaceutical CDMO Basic Information
9.4.2 Thermo Fisher Biopharmaceutical CDMO Product Overview
9.4.3 Thermo Fisher Biopharmaceutical CDMO Product Market Performance
9.4.4 Thermo Fisher Business Overview
9.4.5 Thermo Fisher Recent Developments
9.5 Recipharm
9.5.1 Recipharm Biopharmaceutical CDMO Basic Information
9.5.2 Recipharm Biopharmaceutical CDMO Product Overview
9.5.3 Recipharm Biopharmaceutical CDMO Product Market Performance
9.5.4 Recipharm Business Overview
9.5.5 Recipharm Recent Developments
9.6 Samsung Biologics
9.6.1 Samsung Biologics Biopharmaceutical CDMO Basic Information
9.6.2 Samsung Biologics Biopharmaceutical CDMO Product Overview
9.6.3 Samsung Biologics Biopharmaceutical CDMO Product Market Performance
9.6.4 Samsung Biologics Business Overview
9.6.5 Samsung Biologics Recent Developments
9.7 Siegfried
9.7.1 Siegfried Biopharmaceutical CDMO Basic Information
9.7.2 Siegfried Biopharmaceutical CDMO Product Overview
9.7.3 Siegfried Biopharmaceutical CDMO Product Market Performance
9.7.4 Siegfried Business Overview
9.7.5 Siegfried Recent Developments
9.8 Delpharm
9.8.1 Delpharm Biopharmaceutical CDMO Basic Information
9.8.2 Delpharm Biopharmaceutical CDMO Product Overview
9.8.3 Delpharm Biopharmaceutical CDMO Product Market Performance
9.8.4 Delpharm Business Overview
9.8.5 Delpharm Recent Developments
9.9 Boehringer Ingelheim
9.9.1 Boehringer Ingelheim Biopharmaceutical CDMO Basic Information
9.9.2 Boehringer Ingelheim Biopharmaceutical CDMO Product Overview
9.9.3 Boehringer Ingelheim Biopharmaceutical CDMO Product Market Performance
9.9.4 Boehringer Ingelheim Business Overview
9.9.5 Boehringer Ingelheim Recent Developments
9.10 Aenova Group
9.10.1 Aenova Group Biopharmaceutical CDMO Basic Information
9.10.2 Aenova Group Biopharmaceutical CDMO Product Overview
9.10.3 Aenova Group Biopharmaceutical CDMO Product Market Performance
9.10.4 Aenova Group Business Overview
9.10.5 Aenova Group Recent Developments
9.11 AGC Parma Chemicals
9.11.1 AGC Parma Chemicals Biopharmaceutical CDMO Basic Information
9.11.2 AGC Parma Chemicals Biopharmaceutical CDMO Product Overview
9.11.3 AGC Parma Chemicals Biopharmaceutical CDMO Product Market Performance
9.11.4 AGC Parma Chemicals Business Overview
9.11.5 AGC Parma Chemicals Recent Developments
9.12 GenScript
9.12.1 GenScript Biopharmaceutical CDMO Basic Information
9.12.2 GenScript Biopharmaceutical CDMO Product Overview
9.12.3 GenScript Biopharmaceutical CDMO Product Market Performance
9.12.4 GenScript Business Overview
9.12.5 GenScript Recent Developments
9.13 ProBioGen
9.13.1 ProBioGen Biopharmaceutical CDMO Basic Information
9.13.2 ProBioGen Biopharmaceutical CDMO Product Overview
9.13.3 ProBioGen Biopharmaceutical CDMO Product Market Performance
9.13.4 ProBioGen Business Overview
9.13.5 ProBioGen Recent Developments
9.14 KBI Biopharma
9.14.1 KBI Biopharma Biopharmaceutical CDMO Basic Information
9.14.2 KBI Biopharma Biopharmaceutical CDMO Product Overview
9.14.3 KBI Biopharma Biopharmaceutical CDMO Product Market Performance
9.14.4 KBI Biopharma Business Overview
9.14.5 KBI Biopharma Recent Developments
9.15 3P Biopharmaceuticals
9.15.1 3P Biopharmaceuticals Biopharmaceutical CDMO Basic Information
9.15.2 3P Biopharmaceuticals Biopharmaceutical CDMO Product Overview
9.15.3 3P Biopharmaceuticals Biopharmaceutical CDMO Product Market Performance
9.15.4 3P Biopharmaceuticals Business Overview
9.15.5 3P Biopharmaceuticals Recent Developments
9.16 Rentschler Biopharma
9.16.1 Rentschler Biopharma Biopharmaceutical CDMO Basic Information
9.16.2 Rentschler Biopharma Biopharmaceutical CDMO Product Overview
9.16.3 Rentschler Biopharma Biopharmaceutical CDMO Product Market Performance
9.16.4 Rentschler Biopharma Business Overview
9.16.5 Rentschler Biopharma Recent Developments
9.17 Northway Biotech
9.17.1 Northway Biotech Biopharmaceutical CDMO Basic Information
9.17.2 Northway Biotech Biopharmaceutical CDMO Product Overview
9.17.3 Northway Biotech Biopharmaceutical CDMO Product Market Performance
9.17.4 Northway Biotech Business Overview
9.17.5 Northway Biotech Recent Developments
10 BIOPHARMACEUTICAL CDMO MARKET FORECAST BY REGION
10.1 Global Biopharmaceutical CDMO Market Size Forecast
10.2 Global Biopharmaceutical CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biopharmaceutical CDMO Market Size Forecast by Country
10.2.3 Asia Pacific Biopharmaceutical CDMO Market Size Forecast by Region
10.2.4 South America Biopharmaceutical CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biopharmaceutical CDMO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Biopharmaceutical CDMO Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Biopharmaceutical CDMO by Type (2025-2030)
11.1.2 Global Biopharmaceutical CDMO Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Biopharmaceutical CDMO by Type (2025-2030)
11.2 Global Biopharmaceutical CDMO Market Forecast by Application (2025-2030)
11.2.1 Global Biopharmaceutical CDMO Sales (K Units) Forecast by Application
11.2.2 Global Biopharmaceutical CDMO Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Biopharmaceutical CDMO
1.2 Key Market Segments
1.2.1 Biopharmaceutical CDMO Segment by Type
1.2.2 Biopharmaceutical CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOPHARMACEUTICAL CDMO MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biopharmaceutical CDMO Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Biopharmaceutical CDMO Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOPHARMACEUTICAL CDMO MARKET COMPETITIVE LANDSCAPE
3.1 Global Biopharmaceutical CDMO Sales by Manufacturers (2019-2024)
3.2 Global Biopharmaceutical CDMO Revenue Market Share by Manufacturers (2019-2024)
3.3 Biopharmaceutical CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biopharmaceutical CDMO Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biopharmaceutical CDMO Sales Sites, Area Served, Product Type
3.6 Biopharmaceutical CDMO Market Competitive Situation and Trends
3.6.1 Biopharmaceutical CDMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biopharmaceutical CDMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIOPHARMACEUTICAL CDMO INDUSTRY CHAIN ANALYSIS
4.1 Biopharmaceutical CDMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOPHARMACEUTICAL CDMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BIOPHARMACEUTICAL CDMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biopharmaceutical CDMO Sales Market Share by Type (2019-2024)
6.3 Global Biopharmaceutical CDMO Market Size Market Share by Type (2019-2024)
6.4 Global Biopharmaceutical CDMO Price by Type (2019-2024)
7 BIOPHARMACEUTICAL CDMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biopharmaceutical CDMO Market Sales by Application (2019-2024)
7.3 Global Biopharmaceutical CDMO Market Size (M USD) by Application (2019-2024)
7.4 Global Biopharmaceutical CDMO Sales Growth Rate by Application (2019-2024)
8 BIOPHARMACEUTICAL CDMO MARKET SEGMENTATION BY REGION
8.1 Global Biopharmaceutical CDMO Sales by Region
8.1.1 Global Biopharmaceutical CDMO Sales by Region
8.1.2 Global Biopharmaceutical CDMO Sales Market Share by Region
8.2 North America
8.2.1 North America Biopharmaceutical CDMO Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biopharmaceutical CDMO Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biopharmaceutical CDMO Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biopharmaceutical CDMO Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biopharmaceutical CDMO Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Lonza
9.1.1 Lonza Biopharmaceutical CDMO Basic Information
9.1.2 Lonza Biopharmaceutical CDMO Product Overview
9.1.3 Lonza Biopharmaceutical CDMO Product Market Performance
9.1.4 Lonza Business Overview
9.1.5 Lonza Biopharmaceutical CDMO SWOT Analysis
9.1.6 Lonza Recent Developments
9.2 WuXi AppTec
9.2.1 WuXi AppTec Biopharmaceutical CDMO Basic Information
9.2.2 WuXi AppTec Biopharmaceutical CDMO Product Overview
9.2.3 WuXi AppTec Biopharmaceutical CDMO Product Market Performance
9.2.4 WuXi AppTec Business Overview
9.2.5 WuXi AppTec Biopharmaceutical CDMO SWOT Analysis
9.2.6 WuXi AppTec Recent Developments
9.3 Catalent
9.3.1 Catalent Biopharmaceutical CDMO Basic Information
9.3.2 Catalent Biopharmaceutical CDMO Product Overview
9.3.3 Catalent Biopharmaceutical CDMO Product Market Performance
9.3.4 Catalent Biopharmaceutical CDMO SWOT Analysis
9.3.5 Catalent Business Overview
9.3.6 Catalent Recent Developments
9.4 Thermo Fisher
9.4.1 Thermo Fisher Biopharmaceutical CDMO Basic Information
9.4.2 Thermo Fisher Biopharmaceutical CDMO Product Overview
9.4.3 Thermo Fisher Biopharmaceutical CDMO Product Market Performance
9.4.4 Thermo Fisher Business Overview
9.4.5 Thermo Fisher Recent Developments
9.5 Recipharm
9.5.1 Recipharm Biopharmaceutical CDMO Basic Information
9.5.2 Recipharm Biopharmaceutical CDMO Product Overview
9.5.3 Recipharm Biopharmaceutical CDMO Product Market Performance
9.5.4 Recipharm Business Overview
9.5.5 Recipharm Recent Developments
9.6 Samsung Biologics
9.6.1 Samsung Biologics Biopharmaceutical CDMO Basic Information
9.6.2 Samsung Biologics Biopharmaceutical CDMO Product Overview
9.6.3 Samsung Biologics Biopharmaceutical CDMO Product Market Performance
9.6.4 Samsung Biologics Business Overview
9.6.5 Samsung Biologics Recent Developments
9.7 Siegfried
9.7.1 Siegfried Biopharmaceutical CDMO Basic Information
9.7.2 Siegfried Biopharmaceutical CDMO Product Overview
9.7.3 Siegfried Biopharmaceutical CDMO Product Market Performance
9.7.4 Siegfried Business Overview
9.7.5 Siegfried Recent Developments
9.8 Delpharm
9.8.1 Delpharm Biopharmaceutical CDMO Basic Information
9.8.2 Delpharm Biopharmaceutical CDMO Product Overview
9.8.3 Delpharm Biopharmaceutical CDMO Product Market Performance
9.8.4 Delpharm Business Overview
9.8.5 Delpharm Recent Developments
9.9 Boehringer Ingelheim
9.9.1 Boehringer Ingelheim Biopharmaceutical CDMO Basic Information
9.9.2 Boehringer Ingelheim Biopharmaceutical CDMO Product Overview
9.9.3 Boehringer Ingelheim Biopharmaceutical CDMO Product Market Performance
9.9.4 Boehringer Ingelheim Business Overview
9.9.5 Boehringer Ingelheim Recent Developments
9.10 Aenova Group
9.10.1 Aenova Group Biopharmaceutical CDMO Basic Information
9.10.2 Aenova Group Biopharmaceutical CDMO Product Overview
9.10.3 Aenova Group Biopharmaceutical CDMO Product Market Performance
9.10.4 Aenova Group Business Overview
9.10.5 Aenova Group Recent Developments
9.11 AGC Parma Chemicals
9.11.1 AGC Parma Chemicals Biopharmaceutical CDMO Basic Information
9.11.2 AGC Parma Chemicals Biopharmaceutical CDMO Product Overview
9.11.3 AGC Parma Chemicals Biopharmaceutical CDMO Product Market Performance
9.11.4 AGC Parma Chemicals Business Overview
9.11.5 AGC Parma Chemicals Recent Developments
9.12 GenScript
9.12.1 GenScript Biopharmaceutical CDMO Basic Information
9.12.2 GenScript Biopharmaceutical CDMO Product Overview
9.12.3 GenScript Biopharmaceutical CDMO Product Market Performance
9.12.4 GenScript Business Overview
9.12.5 GenScript Recent Developments
9.13 ProBioGen
9.13.1 ProBioGen Biopharmaceutical CDMO Basic Information
9.13.2 ProBioGen Biopharmaceutical CDMO Product Overview
9.13.3 ProBioGen Biopharmaceutical CDMO Product Market Performance
9.13.4 ProBioGen Business Overview
9.13.5 ProBioGen Recent Developments
9.14 KBI Biopharma
9.14.1 KBI Biopharma Biopharmaceutical CDMO Basic Information
9.14.2 KBI Biopharma Biopharmaceutical CDMO Product Overview
9.14.3 KBI Biopharma Biopharmaceutical CDMO Product Market Performance
9.14.4 KBI Biopharma Business Overview
9.14.5 KBI Biopharma Recent Developments
9.15 3P Biopharmaceuticals
9.15.1 3P Biopharmaceuticals Biopharmaceutical CDMO Basic Information
9.15.2 3P Biopharmaceuticals Biopharmaceutical CDMO Product Overview
9.15.3 3P Biopharmaceuticals Biopharmaceutical CDMO Product Market Performance
9.15.4 3P Biopharmaceuticals Business Overview
9.15.5 3P Biopharmaceuticals Recent Developments
9.16 Rentschler Biopharma
9.16.1 Rentschler Biopharma Biopharmaceutical CDMO Basic Information
9.16.2 Rentschler Biopharma Biopharmaceutical CDMO Product Overview
9.16.3 Rentschler Biopharma Biopharmaceutical CDMO Product Market Performance
9.16.4 Rentschler Biopharma Business Overview
9.16.5 Rentschler Biopharma Recent Developments
9.17 Northway Biotech
9.17.1 Northway Biotech Biopharmaceutical CDMO Basic Information
9.17.2 Northway Biotech Biopharmaceutical CDMO Product Overview
9.17.3 Northway Biotech Biopharmaceutical CDMO Product Market Performance
9.17.4 Northway Biotech Business Overview
9.17.5 Northway Biotech Recent Developments
10 BIOPHARMACEUTICAL CDMO MARKET FORECAST BY REGION
10.1 Global Biopharmaceutical CDMO Market Size Forecast
10.2 Global Biopharmaceutical CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biopharmaceutical CDMO Market Size Forecast by Country
10.2.3 Asia Pacific Biopharmaceutical CDMO Market Size Forecast by Region
10.2.4 South America Biopharmaceutical CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biopharmaceutical CDMO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Biopharmaceutical CDMO Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Biopharmaceutical CDMO by Type (2025-2030)
11.1.2 Global Biopharmaceutical CDMO Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Biopharmaceutical CDMO by Type (2025-2030)
11.2 Global Biopharmaceutical CDMO Market Forecast by Application (2025-2030)
11.2.1 Global Biopharmaceutical CDMO Sales (K Units) Forecast by Application
11.2.2 Global Biopharmaceutical CDMO Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biopharmaceutical CDMO Market Size Comparison by Region (M USD)
Table 5. Global Biopharmaceutical CDMO Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Biopharmaceutical CDMO Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Biopharmaceutical CDMO Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Biopharmaceutical CDMO Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CDMO as of 2022)
Table 10. Global Market Biopharmaceutical CDMO Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Biopharmaceutical CDMO Sales Sites and Area Served
Table 12. Manufacturers Biopharmaceutical CDMO Product Type
Table 13. Global Biopharmaceutical CDMO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biopharmaceutical CDMO
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biopharmaceutical CDMO Market Challenges
Table 22. Global Biopharmaceutical CDMO Sales by Type (K Units)
Table 23. Global Biopharmaceutical CDMO Market Size by Type (M USD)
Table 24. Global Biopharmaceutical CDMO Sales (K Units) by Type (2019-2024)
Table 25. Global Biopharmaceutical CDMO Sales Market Share by Type (2019-2024)
Table 26. Global Biopharmaceutical CDMO Market Size (M USD) by Type (2019-2024)
Table 27. Global Biopharmaceutical CDMO Market Size Share by Type (2019-2024)
Table 28. Global Biopharmaceutical CDMO Price (USD/Unit) by Type (2019-2024)
Table 29. Global Biopharmaceutical CDMO Sales (K Units) by Application
Table 30. Global Biopharmaceutical CDMO Market Size by Application
Table 31. Global Biopharmaceutical CDMO Sales by Application (2019-2024) & (K Units)
Table 32. Global Biopharmaceutical CDMO Sales Market Share by Application (2019-2024)
Table 33. Global Biopharmaceutical CDMO Sales by Application (2019-2024) & (M USD)
Table 34. Global Biopharmaceutical CDMO Market Share by Application (2019-2024)
Table 35. Global Biopharmaceutical CDMO Sales Growth Rate by Application (2019-2024)
Table 36. Global Biopharmaceutical CDMO Sales by Region (2019-2024) & (K Units)
Table 37. Global Biopharmaceutical CDMO Sales Market Share by Region (2019-2024)
Table 38. North America Biopharmaceutical CDMO Sales by Country (2019-2024) & (K Units)
Table 39. Europe Biopharmaceutical CDMO Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Biopharmaceutical CDMO Sales by Region (2019-2024) & (K Units)
Table 41. South America Biopharmaceutical CDMO Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Biopharmaceutical CDMO Sales by Region (2019-2024) & (K Units)
Table 43. Lonza Biopharmaceutical CDMO Basic Information
Table 44. Lonza Biopharmaceutical CDMO Product Overview
Table 45. Lonza Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Lonza Business Overview
Table 47. Lonza Biopharmaceutical CDMO SWOT Analysis
Table 48. Lonza Recent Developments
Table 49. WuXi AppTec Biopharmaceutical CDMO Basic Information
Table 50. WuXi AppTec Biopharmaceutical CDMO Product Overview
Table 51. WuXi AppTec Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. WuXi AppTec Business Overview
Table 53. WuXi AppTec Biopharmaceutical CDMO SWOT Analysis
Table 54. WuXi AppTec Recent Developments
Table 55. Catalent Biopharmaceutical CDMO Basic Information
Table 56. Catalent Biopharmaceutical CDMO Product Overview
Table 57. Catalent Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Catalent Biopharmaceutical CDMO SWOT Analysis
Table 59. Catalent Business Overview
Table 60. Catalent Recent Developments
Table 61. Thermo Fisher Biopharmaceutical CDMO Basic Information
Table 62. Thermo Fisher Biopharmaceutical CDMO Product Overview
Table 63. Thermo Fisher Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Thermo Fisher Business Overview
Table 65. Thermo Fisher Recent Developments
Table 66. Recipharm Biopharmaceutical CDMO Basic Information
Table 67. Recipharm Biopharmaceutical CDMO Product Overview
Table 68. Recipharm Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Recipharm Business Overview
Table 70. Recipharm Recent Developments
Table 71. Samsung Biologics Biopharmaceutical CDMO Basic Information
Table 72. Samsung Biologics Biopharmaceutical CDMO Product Overview
Table 73. Samsung Biologics Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Samsung Biologics Business Overview
Table 75. Samsung Biologics Recent Developments
Table 76. Siegfried Biopharmaceutical CDMO Basic Information
Table 77. Siegfried Biopharmaceutical CDMO Product Overview
Table 78. Siegfried Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Siegfried Business Overview
Table 80. Siegfried Recent Developments
Table 81. Delpharm Biopharmaceutical CDMO Basic Information
Table 82. Delpharm Biopharmaceutical CDMO Product Overview
Table 83. Delpharm Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Delpharm Business Overview
Table 85. Delpharm Recent Developments
Table 86. Boehringer Ingelheim Biopharmaceutical CDMO Basic Information
Table 87. Boehringer Ingelheim Biopharmaceutical CDMO Product Overview
Table 88. Boehringer Ingelheim Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Boehringer Ingelheim Business Overview
Table 90. Boehringer Ingelheim Recent Developments
Table 91. Aenova Group Biopharmaceutical CDMO Basic Information
Table 92. Aenova Group Biopharmaceutical CDMO Product Overview
Table 93. Aenova Group Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Aenova Group Business Overview
Table 95. Aenova Group Recent Developments
Table 96. AGC Parma Chemicals Biopharmaceutical CDMO Basic Information
Table 97. AGC Parma Chemicals Biopharmaceutical CDMO Product Overview
Table 98. AGC Parma Chemicals Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. AGC Parma Chemicals Business Overview
Table 100. AGC Parma Chemicals Recent Developments
Table 101. GenScript Biopharmaceutical CDMO Basic Information
Table 102. GenScript Biopharmaceutical CDMO Product Overview
Table 103. GenScript Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. GenScript Business Overview
Table 105. GenScript Recent Developments
Table 106. ProBioGen Biopharmaceutical CDMO Basic Information
Table 107. ProBioGen Biopharmaceutical CDMO Product Overview
Table 108. ProBioGen Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. ProBioGen Business Overview
Table 110. ProBioGen Recent Developments
Table 111. KBI Biopharma Biopharmaceutical CDMO Basic Information
Table 112. KBI Biopharma Biopharmaceutical CDMO Product Overview
Table 113. KBI Biopharma Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. KBI Biopharma Business Overview
Table 115. KBI Biopharma Recent Developments
Table 116. 3P Biopharmaceuticals Biopharmaceutical CDMO Basic Information
Table 117. 3P Biopharmaceuticals Biopharmaceutical CDMO Product Overview
Table 118. 3P Biopharmaceuticals Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. 3P Biopharmaceuticals Business Overview
Table 120. 3P Biopharmaceuticals Recent Developments
Table 121. Rentschler Biopharma Biopharmaceutical CDMO Basic Information
Table 122. Rentschler Biopharma Biopharmaceutical CDMO Product Overview
Table 123. Rentschler Biopharma Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Rentschler Biopharma Business Overview
Table 125. Rentschler Biopharma Recent Developments
Table 126. Northway Biotech Biopharmaceutical CDMO Basic Information
Table 127. Northway Biotech Biopharmaceutical CDMO Product Overview
Table 128. Northway Biotech Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Northway Biotech Business Overview
Table 130. Northway Biotech Recent Developments
Table 131. Global Biopharmaceutical CDMO Sales Forecast by Region (2025-2030) & (K Units)
Table 132. Global Biopharmaceutical CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America Biopharmaceutical CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 134. North America Biopharmaceutical CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe Biopharmaceutical CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 136. Europe Biopharmaceutical CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific Biopharmaceutical CDMO Sales Forecast by Region (2025-2030) & (K Units)
Table 138. Asia Pacific Biopharmaceutical CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America Biopharmaceutical CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 140. South America Biopharmaceutical CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa Biopharmaceutical CDMO Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa Biopharmaceutical CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global Biopharmaceutical CDMO Sales Forecast by Type (2025-2030) & (K Units)
Table 144. Global Biopharmaceutical CDMO Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global Biopharmaceutical CDMO Price Forecast by Type (2025-2030) & (USD/Unit)
Table 146. Global Biopharmaceutical CDMO Sales (K Units) Forecast by Application (2025-2030)
Table 147. Global Biopharmaceutical CDMO Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biopharmaceutical CDMO Market Size Comparison by Region (M USD)
Table 5. Global Biopharmaceutical CDMO Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Biopharmaceutical CDMO Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Biopharmaceutical CDMO Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Biopharmaceutical CDMO Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CDMO as of 2022)
Table 10. Global Market Biopharmaceutical CDMO Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Biopharmaceutical CDMO Sales Sites and Area Served
Table 12. Manufacturers Biopharmaceutical CDMO Product Type
Table 13. Global Biopharmaceutical CDMO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biopharmaceutical CDMO
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biopharmaceutical CDMO Market Challenges
Table 22. Global Biopharmaceutical CDMO Sales by Type (K Units)
Table 23. Global Biopharmaceutical CDMO Market Size by Type (M USD)
Table 24. Global Biopharmaceutical CDMO Sales (K Units) by Type (2019-2024)
Table 25. Global Biopharmaceutical CDMO Sales Market Share by Type (2019-2024)
Table 26. Global Biopharmaceutical CDMO Market Size (M USD) by Type (2019-2024)
Table 27. Global Biopharmaceutical CDMO Market Size Share by Type (2019-2024)
Table 28. Global Biopharmaceutical CDMO Price (USD/Unit) by Type (2019-2024)
Table 29. Global Biopharmaceutical CDMO Sales (K Units) by Application
Table 30. Global Biopharmaceutical CDMO Market Size by Application
Table 31. Global Biopharmaceutical CDMO Sales by Application (2019-2024) & (K Units)
Table 32. Global Biopharmaceutical CDMO Sales Market Share by Application (2019-2024)
Table 33. Global Biopharmaceutical CDMO Sales by Application (2019-2024) & (M USD)
Table 34. Global Biopharmaceutical CDMO Market Share by Application (2019-2024)
Table 35. Global Biopharmaceutical CDMO Sales Growth Rate by Application (2019-2024)
Table 36. Global Biopharmaceutical CDMO Sales by Region (2019-2024) & (K Units)
Table 37. Global Biopharmaceutical CDMO Sales Market Share by Region (2019-2024)
Table 38. North America Biopharmaceutical CDMO Sales by Country (2019-2024) & (K Units)
Table 39. Europe Biopharmaceutical CDMO Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Biopharmaceutical CDMO Sales by Region (2019-2024) & (K Units)
Table 41. South America Biopharmaceutical CDMO Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Biopharmaceutical CDMO Sales by Region (2019-2024) & (K Units)
Table 43. Lonza Biopharmaceutical CDMO Basic Information
Table 44. Lonza Biopharmaceutical CDMO Product Overview
Table 45. Lonza Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Lonza Business Overview
Table 47. Lonza Biopharmaceutical CDMO SWOT Analysis
Table 48. Lonza Recent Developments
Table 49. WuXi AppTec Biopharmaceutical CDMO Basic Information
Table 50. WuXi AppTec Biopharmaceutical CDMO Product Overview
Table 51. WuXi AppTec Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. WuXi AppTec Business Overview
Table 53. WuXi AppTec Biopharmaceutical CDMO SWOT Analysis
Table 54. WuXi AppTec Recent Developments
Table 55. Catalent Biopharmaceutical CDMO Basic Information
Table 56. Catalent Biopharmaceutical CDMO Product Overview
Table 57. Catalent Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Catalent Biopharmaceutical CDMO SWOT Analysis
Table 59. Catalent Business Overview
Table 60. Catalent Recent Developments
Table 61. Thermo Fisher Biopharmaceutical CDMO Basic Information
Table 62. Thermo Fisher Biopharmaceutical CDMO Product Overview
Table 63. Thermo Fisher Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Thermo Fisher Business Overview
Table 65. Thermo Fisher Recent Developments
Table 66. Recipharm Biopharmaceutical CDMO Basic Information
Table 67. Recipharm Biopharmaceutical CDMO Product Overview
Table 68. Recipharm Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Recipharm Business Overview
Table 70. Recipharm Recent Developments
Table 71. Samsung Biologics Biopharmaceutical CDMO Basic Information
Table 72. Samsung Biologics Biopharmaceutical CDMO Product Overview
Table 73. Samsung Biologics Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Samsung Biologics Business Overview
Table 75. Samsung Biologics Recent Developments
Table 76. Siegfried Biopharmaceutical CDMO Basic Information
Table 77. Siegfried Biopharmaceutical CDMO Product Overview
Table 78. Siegfried Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Siegfried Business Overview
Table 80. Siegfried Recent Developments
Table 81. Delpharm Biopharmaceutical CDMO Basic Information
Table 82. Delpharm Biopharmaceutical CDMO Product Overview
Table 83. Delpharm Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Delpharm Business Overview
Table 85. Delpharm Recent Developments
Table 86. Boehringer Ingelheim Biopharmaceutical CDMO Basic Information
Table 87. Boehringer Ingelheim Biopharmaceutical CDMO Product Overview
Table 88. Boehringer Ingelheim Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Boehringer Ingelheim Business Overview
Table 90. Boehringer Ingelheim Recent Developments
Table 91. Aenova Group Biopharmaceutical CDMO Basic Information
Table 92. Aenova Group Biopharmaceutical CDMO Product Overview
Table 93. Aenova Group Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Aenova Group Business Overview
Table 95. Aenova Group Recent Developments
Table 96. AGC Parma Chemicals Biopharmaceutical CDMO Basic Information
Table 97. AGC Parma Chemicals Biopharmaceutical CDMO Product Overview
Table 98. AGC Parma Chemicals Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. AGC Parma Chemicals Business Overview
Table 100. AGC Parma Chemicals Recent Developments
Table 101. GenScript Biopharmaceutical CDMO Basic Information
Table 102. GenScript Biopharmaceutical CDMO Product Overview
Table 103. GenScript Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. GenScript Business Overview
Table 105. GenScript Recent Developments
Table 106. ProBioGen Biopharmaceutical CDMO Basic Information
Table 107. ProBioGen Biopharmaceutical CDMO Product Overview
Table 108. ProBioGen Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. ProBioGen Business Overview
Table 110. ProBioGen Recent Developments
Table 111. KBI Biopharma Biopharmaceutical CDMO Basic Information
Table 112. KBI Biopharma Biopharmaceutical CDMO Product Overview
Table 113. KBI Biopharma Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. KBI Biopharma Business Overview
Table 115. KBI Biopharma Recent Developments
Table 116. 3P Biopharmaceuticals Biopharmaceutical CDMO Basic Information
Table 117. 3P Biopharmaceuticals Biopharmaceutical CDMO Product Overview
Table 118. 3P Biopharmaceuticals Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. 3P Biopharmaceuticals Business Overview
Table 120. 3P Biopharmaceuticals Recent Developments
Table 121. Rentschler Biopharma Biopharmaceutical CDMO Basic Information
Table 122. Rentschler Biopharma Biopharmaceutical CDMO Product Overview
Table 123. Rentschler Biopharma Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Rentschler Biopharma Business Overview
Table 125. Rentschler Biopharma Recent Developments
Table 126. Northway Biotech Biopharmaceutical CDMO Basic Information
Table 127. Northway Biotech Biopharmaceutical CDMO Product Overview
Table 128. Northway Biotech Biopharmaceutical CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Northway Biotech Business Overview
Table 130. Northway Biotech Recent Developments
Table 131. Global Biopharmaceutical CDMO Sales Forecast by Region (2025-2030) & (K Units)
Table 132. Global Biopharmaceutical CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America Biopharmaceutical CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 134. North America Biopharmaceutical CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe Biopharmaceutical CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 136. Europe Biopharmaceutical CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific Biopharmaceutical CDMO Sales Forecast by Region (2025-2030) & (K Units)
Table 138. Asia Pacific Biopharmaceutical CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America Biopharmaceutical CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 140. South America Biopharmaceutical CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa Biopharmaceutical CDMO Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa Biopharmaceutical CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global Biopharmaceutical CDMO Sales Forecast by Type (2025-2030) & (K Units)
Table 144. Global Biopharmaceutical CDMO Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global Biopharmaceutical CDMO Price Forecast by Type (2025-2030) & (USD/Unit)
Table 146. Global Biopharmaceutical CDMO Sales (K Units) Forecast by Application (2025-2030)
Table 147. Global Biopharmaceutical CDMO Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Biopharmaceutical CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biopharmaceutical CDMO Market Size (M USD), 2019-2030
Figure 5. Global Biopharmaceutical CDMO Market Size (M USD) (2019-2030)
Figure 6. Global Biopharmaceutical CDMO Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biopharmaceutical CDMO Market Size by Country (M USD)
Figure 11. Biopharmaceutical CDMO Sales Share by Manufacturers in 2023
Figure 12. Global Biopharmaceutical CDMO Revenue Share by Manufacturers in 2023
Figure 13. Biopharmaceutical CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Biopharmaceutical CDMO Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biopharmaceutical CDMO Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biopharmaceutical CDMO Market Share by Type
Figure 18. Sales Market Share of Biopharmaceutical CDMO by Type (2019-2024)
Figure 19. Sales Market Share of Biopharmaceutical CDMO by Type in 2023
Figure 20. Market Size Share of Biopharmaceutical CDMO by Type (2019-2024)
Figure 21. Market Size Market Share of Biopharmaceutical CDMO by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biopharmaceutical CDMO Market Share by Application
Figure 24. Global Biopharmaceutical CDMO Sales Market Share by Application (2019-2024)
Figure 25. Global Biopharmaceutical CDMO Sales Market Share by Application in 2023
Figure 26. Global Biopharmaceutical CDMO Market Share by Application (2019-2024)
Figure 27. Global Biopharmaceutical CDMO Market Share by Application in 2023
Figure 28. Global Biopharmaceutical CDMO Sales Growth Rate by Application (2019-2024)
Figure 29. Global Biopharmaceutical CDMO Sales Market Share by Region (2019-2024)
Figure 30. North America Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Biopharmaceutical CDMO Sales Market Share by Country in 2023
Figure 32. U.S. Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Biopharmaceutical CDMO Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Biopharmaceutical CDMO Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Biopharmaceutical CDMO Sales Market Share by Country in 2023
Figure 37. Germany Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Biopharmaceutical CDMO Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Biopharmaceutical CDMO Sales Market Share by Region in 2023
Figure 44. China Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Biopharmaceutical CDMO Sales and Growth Rate (K Units)
Figure 50. South America Biopharmaceutical CDMO Sales Market Share by Country in 2023
Figure 51. Brazil Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Biopharmaceutical CDMO Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Biopharmaceutical CDMO Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Biopharmaceutical CDMO Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Biopharmaceutical CDMO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Biopharmaceutical CDMO Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Biopharmaceutical CDMO Market Share Forecast by Type (2025-2030)
Figure 65. Global Biopharmaceutical CDMO Sales Forecast by Application (2025-2030)
Figure 66. Global Biopharmaceutical CDMO Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Biopharmaceutical CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biopharmaceutical CDMO Market Size (M USD), 2019-2030
Figure 5. Global Biopharmaceutical CDMO Market Size (M USD) (2019-2030)
Figure 6. Global Biopharmaceutical CDMO Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biopharmaceutical CDMO Market Size by Country (M USD)
Figure 11. Biopharmaceutical CDMO Sales Share by Manufacturers in 2023
Figure 12. Global Biopharmaceutical CDMO Revenue Share by Manufacturers in 2023
Figure 13. Biopharmaceutical CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Biopharmaceutical CDMO Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biopharmaceutical CDMO Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biopharmaceutical CDMO Market Share by Type
Figure 18. Sales Market Share of Biopharmaceutical CDMO by Type (2019-2024)
Figure 19. Sales Market Share of Biopharmaceutical CDMO by Type in 2023
Figure 20. Market Size Share of Biopharmaceutical CDMO by Type (2019-2024)
Figure 21. Market Size Market Share of Biopharmaceutical CDMO by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biopharmaceutical CDMO Market Share by Application
Figure 24. Global Biopharmaceutical CDMO Sales Market Share by Application (2019-2024)
Figure 25. Global Biopharmaceutical CDMO Sales Market Share by Application in 2023
Figure 26. Global Biopharmaceutical CDMO Market Share by Application (2019-2024)
Figure 27. Global Biopharmaceutical CDMO Market Share by Application in 2023
Figure 28. Global Biopharmaceutical CDMO Sales Growth Rate by Application (2019-2024)
Figure 29. Global Biopharmaceutical CDMO Sales Market Share by Region (2019-2024)
Figure 30. North America Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Biopharmaceutical CDMO Sales Market Share by Country in 2023
Figure 32. U.S. Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Biopharmaceutical CDMO Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Biopharmaceutical CDMO Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Biopharmaceutical CDMO Sales Market Share by Country in 2023
Figure 37. Germany Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Biopharmaceutical CDMO Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Biopharmaceutical CDMO Sales Market Share by Region in 2023
Figure 44. China Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Biopharmaceutical CDMO Sales and Growth Rate (K Units)
Figure 50. South America Biopharmaceutical CDMO Sales Market Share by Country in 2023
Figure 51. Brazil Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Biopharmaceutical CDMO Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Biopharmaceutical CDMO Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Biopharmaceutical CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Biopharmaceutical CDMO Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Biopharmaceutical CDMO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Biopharmaceutical CDMO Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Biopharmaceutical CDMO Market Share Forecast by Type (2025-2030)
Figure 65. Global Biopharmaceutical CDMO Sales Forecast by Application (2025-2030)
Figure 66. Global Biopharmaceutical CDMO Market Share Forecast by Application (2025-2030)
